Back to Journals » Transplant Research and Risk Management » Volume 3

Transplant Research and Risk Management


Archive: Volume 3, 2011

Facial transplantation: a review of ethics, progress, and future targets

Edwards JA, Mathes DW

Transplant Research and Risk Management 2011, 3:113-125

Published Date: 5 September 2011

Everolimus in kidney transplantation

Cooper JE, Christians U, Wiseman AC

Transplant Research and Risk Management 2011, 3:97-112

Published Date: 8 July 2011

Critical appraisal of belatacept for prophylaxis of rejection in kidney transplant patients

Martin ST, Tsapepas D, Gabardi S, Chandraker A

Transplant Research and Risk Management 2011, 3:65-75

Published Date: 12 April 2011

Mycophenolic acid agents: is enteric coating the answer?

Manitpisitkul W, Lee S, Cooper M

Transplant Research and Risk Management 2011, 3:45-53

Published Date: 29 March 2011

Pathophysiology, prevention, and treatment of acute graft-versus-host disease

Abhinav Deol, Voravit Ratanatharathorn, Joseph P Uberti

Transplant Research and Risk Management 2011, 3:31-44

Published Date: 7 March 2011

Impact of everolimus: update on immunosuppressive therapy strategies and patient outcomes after renal transplantation

Helio Tedesco-Silva Jr, Claudia Rosso Felipe, Tainá Veras de Sandes Freitas, et al

Transplant Research and Risk Management 2011, 3:9-29

Published Date: 24 January 2011

Human amniotic membrane, best healing accelerator, and the choice of bone induction for vestibuloplasty technique (an animal study)

Mohammad H Samandari, Shahriar Adibi, Ahad Khoshzaban, et al

Transplant Research and Risk Management 2011, 3:1-8

Published Date: 22 December 2010